BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21598252)

  • 1. Down-regulation of spinophilin in lung tumours contributes to tumourigenesis.
    Molina-Pinelo S; Ferrer I; Blanco-Aparicio C; Peregrino S; Pastor MD; Alvarez-Vega J; Suarez R; Verge M; Marin JJ; Hernandez-Losa J; Ramon y Cajal S; Paz-Ares L; Carnero A
    J Pathol; 2011 Sep; 225(1):73-82. PubMed ID: 21598252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.
    Ferrer I; Verdugo-Sivianes EM; Castilla MA; Melendez R; Marin JJ; Muñoz-Galvan S; Lopez-Guerra JL; Vieites B; Ortiz-Gordillo MJ; De León JM; Praena-Fernandez JM; Perez M; Palacios J; Carnero A
    Oncogene; 2016 May; 35(21):2777-88. PubMed ID: 26387546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinophilin loss correlates with poor patient prognosis in advanced stages of colon carcinoma.
    Estevez-Garcia P; Lopez-Calderero I; Molina-Pinelo S; Muñoz-Galvan S; Salinas A; Gomez-Izquierdo L; Lucena-Cacace A; Felipe-Abrio B; Paz-Ares L; Garcia-Carbonero R; Carnero A
    Clin Cancer Res; 2013 Jul; 19(14):3925-35. PubMed ID: 23729363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinophilin: a new tumor suppressor at 17q21.
    Carnero A
    Curr Mol Med; 2012 Jun; 12(5):528-35. PubMed ID: 22515982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinophilin loss contributes to tumorigenesis in vivo.
    Ferrer I; Peregrino S; Cañamero M; Cecilia Y; Blanco-Aparicio C; Carnero A
    Cell Cycle; 2011 Jun; 10(12):1948-55. PubMed ID: 21670604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J; Huang CL; Liu D; Ueno M; Sumitomo S; Yokomise H
    Int J Oncol; 2005 Nov; 27(5):1215-21. PubMed ID: 16211215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients.
    Kameyama K; Huang CL; Liu D; Masuya D; Nakashima T; Sumitomo S; Takami Y; Kinoshita M; Yokomise H
    Clin Cancer Res; 2003 Oct; 9(13):4926-34. PubMed ID: 14581367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells.
    Verdugo-Sivianes EM; Rojas AM; Muñoz-Galván S; Otero-Albiol D; Carnero A
    Theranostics; 2021; 11(7):3452-3471. PubMed ID: 33537097
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
    Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG
    J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas.
    Valbuena A; Suárez-Gauthier A; López-Rios F; López-Encuentra A; Blanco S; Fernández PL; Sánchez-Céspedes M; Lazo PA
    Lung Cancer; 2007 Dec; 58(3):303-9. PubMed ID: 17689819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation.
    Ferrer I; Blanco-Aparicio C; Peregrina S; Cañamero M; Fominaya J; Cecilia Y; Lleonart M; Hernandez-Losa J; Ramon y Cajal S; Carnero A
    Cell Cycle; 2011 Aug; 10(16):2751-62. PubMed ID: 21772120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
    Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
    Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.
    Boldrini L; Faviana P; Pistolesi F; Gisfredi S; Di Quirico D; Lucchi M; Mussi A; Angeletti CA; Baldinotti F; Fogli A; Simi P; Basolo F; Fontanini G
    Oncogene; 2001 Oct; 20(45):6632-7. PubMed ID: 11641789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SEL1L expression in non-small cell lung cancer.
    Ferrero S; Falleni M; Cattaneo M; Malferrari G; Canton C; Biagiotti L; Maggioni M; Nosotti M; Coggi G; Bosari S; Biunno I
    Hum Pathol; 2006 May; 37(5):505-12. PubMed ID: 16647946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
    Gu J; Zhang L; Swisher SG; Liu J; Roth JA; Fang B
    Oncogene; 2004 Feb; 23(6):1300-7. PubMed ID: 14676844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.